Recent Updates
Recently added Catalysts
MXCT Positive Sentiment

MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference

Wednesday, May 29, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: MaxCyte, Inc. will participate in the William Blair 44th Annual Growth Stock Conference on June 5th at 2:40 pm CT. This event signifies the company's commitment to engaging with investors and increasing its visibility in the biopharma space. Attendees can access a live and archived webcast of the event on the company's investor relations website.
Price reaction · baseline $4.83 (2024-05-28 close) · hit after-hours · clean, no other MXCT news in the window
day 0 close · peak
-3.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • MaxCyte is showcasing its growth potential by participating in a prominent conference.
  • The event provides a platform for increasing visibility among investors.
  • The participation highlights MaxCyte's position in the cell-engineering technology landscape.

Full Press Release Details

ROCKVILLE, Md., May 29, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced Company management will participate at the William Blair 44th Annual Growth Stock Conference on Wednesday, June 5th at 2:40 pm CT.
A live and archived webcast of the event will be available on the “Events” section of the MaxCyte investor relations website at https://investors.maxcyte.com/.
Spectrum Seismic Collaborative
abolshem@spectrumscience.com
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley

Frequently Asked Questions

When is MaxCyte's participation in the William Blair Conference?

MaxCyte will participate in the William Blair 44th Annual Growth Stock Conference on June 5th at 2:40 pm CT.

Where can I find the webcast of the conference?

The live and archived webcast will be available in the 'Events' section of MaxCyte's investor relations website.

What is MaxCyte focused on?

MaxCyte is focused on cell-engineering technologies for cell-based therapeutics and bioprocessing applications.

What stock exchanges is MaxCyte listed on?

MaxCyte is listed on NASDAQ and LSE under the ticker symbol MXCT.

ShareAdd on Google
Tags: MXCT Viatris Investor Conferences Healthcare MaxCyte William Blair growth conference biopharmaceuticals
Last updated: May 29, 2024

Biotech snapshot

Cash runway
$106M liquidity · $2M/mo burn
~67 mo
Minimal dilution risk